Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Century Therapeutics Inc (IPSC)

Century Therapeutics Inc (IPSC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Century Therapeutics Inc 25 N 38 th Street 11th Floor PHILADELPHIA PA 19104 USA

www.centurytx.com Employees: 78 P: 267-817-5790

Sector:

Medical

Description:

Century Therapeutics Inc. is a cell therapy company. It involved in developing induced pluripotent stem cell -derived cell therapies in immuno-oncology. Century Therapeutics Inc. is based in PHILADELPHIA.

Key Statistics

Overview:

Market Capitalization, $K 406,174
Enterprise Value, $K 344,344
Shares Outstanding, K 179,723
Float, K 171,869
% Float 95.63%
Short Interest, K 8,627
Short Float 4.80%
Days to Cover 6.27
Short Volume Ratio 0.60
% of Insider Shareholders 4.37%
% of Institutional Shareholders 50.20%

Financials:

Annual Sales, $ 109,160 K
Annual Net Income, $ -9,580 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -19,180 K
EBIT, $ -17,260 K
EBITDA, $ -6,520 K

Growth:

1-Year Return 498.82%
3-Year Return -27.33%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.25 on 03/12/26
Next Earnings Date 05/21/26
Earnings Per Share ttm -0.06
EPS Growth vs. Prev Qtr 21.87%
EPS Growth vs. Prev Year 41.86%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

IPSC Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -1.43%
Return-on-Assets % -1.05%
Profit Margin % -8.78%
Debt/Equity 0.00
Price/Sales 3.61
Price/Cash Flow 160.15
Price/Book 1.17
Book Value/Share 1.82
Interest Coverage -0.69
60-Month Beta 1.66
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.